Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesopohagus, with special reference to uninvolved mucosa

Journal of Pathology

Volumn 181, Issue 2, 1997, Pages 153-157

  Mandard, Anne Marie ^a   Marnay, Jacques ^a   Lebeau, Christian ^a   Benard, Sandrine ^a   Mandard, Jean Claude ^b  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Chronic oesophagitis; Intraepithelial neoplasia; Oesophageal squamous cell carcinoma; Oesophagus; p53

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CHRONIC DISEASE; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; HUMANS; IMMUNOENZYME TECHNIQUES; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031018052     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199702)181:2<153::AID-PATH743>3.0.CO;2-A     Document Type: Article

References (25)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
2. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 1992; 140: 145-153.
3. Bennett WP, Hollstein MC, He A, et al. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 1991; 6: 1779-1784.
4. Hollstein MC, Peri L, Mandard AM. et al. Genetic analysis of Immun esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991; 51: 4102-4106.
5. Sasano H, Miyazaki S, Gooukon Y, Nishihira T, Sawai T, Nagura H. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992; 23: 1238-1243.
6. Imuzeki F, Omata M, Nose H, Ohto M, Isono K. p53 gene mutations in gastric and esophageal cancers. Gastroenterology 1992; 103: 892-896.
7. Coltrera MD, Zarbo RJ, Sakr WA, Gown AM. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA. p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol 1992; 41: 817-825.
8. Bennett WP, Hollstein MC, Metcalf RA, et al. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992; 52: 6092-6097.
9. Stemmermann G, Heffelfinger SC, Nosffsinger SC, Hui YZ, Miller MA, Fenoglio-Preiser CM. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumour suppressor genes, and growth factors. Hum Pathol 1994; 25: 968-981.
10. Wang LD, Hong JH, Qiu SL, Gao H, Yang CS. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 1993; 53: 1783-1787.
11. Wang DY, Xiang YY, Tanaka M, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian. China and its relationship to progression and prognosis. Cancer 1994; 74: 3089-3096.
12. Crespi M, Munoz N, Grassi A, Aramesh B, Amiri G, Mojtabai A. Esophageal lesions in northern Iran: a premalignant condition? Lancet 1979; ii: 217-220.
13. Munoz N, Crespi M, Grassi A, Aramesh B, Amiri G, Mojtabai A, Precursor lesions of esophageal cancer in high-risk populations in Iran and China. Lancet 1982; i: 876-879.
14. Crespi M, Grassi A, Munoz N, Guo-Quing W, Guanrei Y. Endoscopic features of suspected precancerous lesions in high risk areas for esophageal cancer. Endoscopy 1984; 16: 85-91.
15. Crespi M, Munoz N, Grassi A, Qiong S, Jing WK, Jien LJ. Precursor lesions of esophageal cancer in a low-risk population in China: comparison with high-risk populations. Int J Cancer 1984; 34: 599-602.
16. Jacob JH, Riviere A, Mandard AM, et al. Prevalence survey of precancerous lesions of the esophagus in a high-risk population for esophageal cancer in France. Eur J Cancer Prevent 1993; 2: 53-59.
17. Mandard AM, Tourneux J, Lechaux M, Marnay J, Mandard JC. A study method of esophago-gastrectomy specimens in esophageal cancer. Acta Endosc 1981; XI: 293-298.
18. Dalibard F, Marnay J, Mandard AM, Méthode pour l'étude histologique de l'oesophage in toto [a simple method for the histological study of the entire esophagus]. Ann Pathol 1990; 10: 47-49.
19. Watanabe H, Jass JR, Sobin LH. World Health Organization International Histological Classification of Tumours, Histological Typing of Esophugeal and Gastric Tumours, 2nd edn. Berlin: Springer-Verlag, 1990.
20. Mandard AM, Marnay J, Gignoux M, et al. Cancer of the esophagus and associated lesions: detailed pathologic study of 100 esophagectomy specimens. Hum Pathol 1984; 5: 660-669.
21. Nakanishi Y, Noguchi M, Matsuno Y, et al. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Cancer 1995; 75: 1657-1662.
22. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994; 84: 2412-2421.
23. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988; 8: 531-539.
24. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-679.
25. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785-1789.